BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Piñero F, Thompson M, Marín JI, Silva M. Lenvatinib as first-line therapy for recurrent hepatocellular carcinoma after liver transplantation: Is the current evidence applicable to these patients? World J Transplant 2020; 10(11): 297-306 [PMID: 33312891 DOI: 10.5500/wjt.v10.i11.297]
URL: https://www.wjgnet.com/1007-9327/full/v10/i11/297.htm
Number Citing Articles
Yen-Yang Chen, Chao-Long Chen, Chih-Che Lin, Chih-Chi Wang, Yueh-Wei Liu, Wei-Feng Li, Yen-Hao Chen. Efficacy and Safety of Lenvatinib in Hepatocellular Carcinoma Patients with Liver Transplantation: A Case-Control StudyCancers 2021; 13(18): 4584 doi: 10.3390/cancers13184584
Marie Decraecker, Caroline Toulouse, Jean-Frédéric Blanc. Is There Still a Place for Tyrosine Kinase Inhibitors for the Treatment of Hepatocellular Carcinoma at the Time of Immunotherapies? A Focus on LenvatinibCancers 2021; 13(24): 6310 doi: 10.3390/cancers13246310
Mehmet Akce, Bassel F. El-Rayes, Tanios S. Bekaii-Saab. Frontline therapy for advanced hepatocellular carcinoma: an updateTherapeutic Advances in Gastroenterology 2022; 15: 175628482210861 doi: 10.1177/17562848221086126
Jing Liang, Yi Bai, Fu-Shuang Ha, Ying Luo, Hui-Ting Deng, Ying-Tang Gao. Combining local regional therapy and systemic therapy: Expected changes in the treatment landscape of recurrent hepatocellular carcinomaWorld Journal of Gastrointestinal Oncology 2023; 15(1): 1-18 doi: 10.4251/wjgo.v15.i1.1
Reimi Suzuki, Ryoichi Goto, Norio Kawamura, Masaaki Watanabe, Yoshikazu Ganchiku, Kanako C Hatanaka, Yutaka Hatanaka, Toshiya Kamiyama, Tsuyoshi Shimamura, Akinobu Taketomi. Efficient multiple treatments including molecular targeting agents in a case of recurrent hepatocellular carcinoma, post-living donor liver transplantationClinical Journal of Gastroenterology 2022; 15(4): 755 doi: 10.1007/s12328-022-01643-3
Kyunghye Bang, Andrea Casadei‐Gardini, Changhoon Yoo, Massimo Iavarone, Min‐Hee Ryu, Sook Ryun Park, Hyung‐Don Kim, Young‐In Yoon, Dong‐Hwan Jung, Gil‐Chun Park, Chul‐Soo Ahn, Deok‐Bog Moon, Shin Hwang, Ki‐Hun Kim, Gi‐Won Song, Chiara Mazzarelli, Eleonora Alimenti, Stephen L. Chan, Massimo De Giorgio, Baek‐Yeol Ryoo, Sung‐Gyu Lee. Efficacy and safety of lenvatinib in patients with recurrent hepatocellular carcinoma after liver transplantationCancer Medicine 2023; 12(3): 2572 doi: 10.1002/cam4.5123
Filippo Pelizzaro, Martina Gambato, Enrico Gringeri, Alessandro Vitale, Umberto Cillo, Fabio Farinati, Patrizia Burra, Francesco Paolo Russo. Management of Hepatocellular Carcinoma Recurrence after Liver TransplantationCancers 2021; 13(19): 4882 doi: 10.3390/cancers13194882